222 related articles for article (PubMed ID: 22824341)
1. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.
Papanastasiou AD; Sirinian C; Kalofonos HP
Breast Cancer Res; 2012 Jul; 14(4):R112. PubMed ID: 22824341
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-κB.
Sirinian C; Papanastasiou AD; Zarkadis IK; Kalofonos HP
Gene; 2013 Aug; 525(1):124-9. PubMed ID: 23664977
[TBL] [Abstract][Full Text] [Related]
3. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.
Sirinian C; Papanastasiou AD; Schizas M; Spella M; Stathopoulos GT; Repanti M; Zarkadis IK; King TA; Kalofonos HP
Oncogene; 2018 Sep; 37(37):5101-5114. PubMed ID: 29844572
[TBL] [Abstract][Full Text] [Related]
4. RANK and EGFR in invasive breast carcinoma.
Papanastasiou AD; Sirinian C; Plakoula E; Zolota V; Zarkadis IK; Kalofonos HP
Cancer Genet; 2017 Oct; 216-217():61-66. PubMed ID: 29025596
[TBL] [Abstract][Full Text] [Related]
5. Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas.
Zoi I; Karamouzis MV; Xingi E; Sarantis P; Thomaidou D; Lembessis P; Theocharis S; Papavassiliou AG
Breast Cancer Res; 2019 Dec; 21(1):132. PubMed ID: 31796128
[TBL] [Abstract][Full Text] [Related]
6. RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.
von dem Knesebeck A; Felsberg J; Waha A; Hartmann W; Scheffler B; Glas M; Hammes J; Mikeska T; Yan PS; Endl E; Simon M; Reifenberger G; Pietsch T; Waha A
Neoplasia; 2012 Jun; 14(6):526-34. PubMed ID: 22787434
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
[TBL] [Abstract][Full Text] [Related]
8. KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression.
Ma D; Chang LY; Zhao S; Zhao JJ; Xiong YJ; Cao FY; Yuan L; Zhang Q; Wang XY; Geng ML; Zheng HY; Li O
Sci Rep; 2017 Nov; 7(1):15683. PubMed ID: 29146991
[TBL] [Abstract][Full Text] [Related]
9. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
10. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
11. RANKL and RANK: From Mammalian Physiology to Cancer Treatment.
Rao S; Cronin SJF; Sigl V; Penninger JM
Trends Cell Biol; 2018 Mar; 28(3):213-223. PubMed ID: 29241686
[TBL] [Abstract][Full Text] [Related]
12. RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs).
Sirinian C; Papanastasiou AD; Degn SE; Frantzi T; Aronis C; Chaniotis D; Makatsoris T; Koutras A; Kalofonos HP
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828291
[TBL] [Abstract][Full Text] [Related]
13. The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?
Li R; Zhang K; Penedo TL; Kragel CP; Grizzle WE; Hameed O; Siegal GP; Wei S
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):42-50. PubMed ID: 26200837
[TBL] [Abstract][Full Text] [Related]
14. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
15. Expressions and Functions of Krüppel Like Factor 5 and Tumor Necrosis Factor Receptor Superfamily Member 11a in Cervical Cancer Tissues and Cells.
Chang L; Ma D; Li O; Wang X; Zhang Q; Zhang L; Yan X; Zheng H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):196-205. PubMed ID: 28483017
[TBL] [Abstract][Full Text] [Related]
16. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
17. MiR-3150b-3p inhibits the proliferation and invasion of cervical cancer cells by targeting TNFRSF11a.
Yu Z; Wang L; Li X
J Investig Med; 2020 Aug; 68(6):1166-1170. PubMed ID: 32616510
[TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of function of a novel splicing variant of mouse receptor activator of NF-κB.
Mukai S; Kitazawa R; Ishii J; Kondo T; Hakozaki A; Horiuchi K; Haraguch R; Mori K; Kitazawa S
Mol Cell Biochem; 2011 Apr; 350(1-2):29-38. PubMed ID: 21153864
[TBL] [Abstract][Full Text] [Related]
19. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
Azim HA; Peccatori FA; Brohée S; Branstetter D; Loi S; Viale G; Piccart M; Dougall WC; Pruneri G; Sotiriou C
Breast Cancer Res; 2015 Feb; 17():24. PubMed ID: 25849336
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells.
Tang ZN; Zhang F; Tang P; Qi XW; Jiang J
Biochem Biophys Res Commun; 2011 May; 408(3):411-6. PubMed ID: 21514280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
